plicamycin has been researched along with Colonic Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belka, C; Daniel, PT; Essmann, F; Gillissen, B; Hemmati, PG; Overkamp, T; Preissner, R; Richter, A | 1 |
| Bataller, M; Méndez, C; Portugal, J; Salas, JA | 1 |
| Garcia-Ferrer, I; Mansilla, S; Méndez, C; Portugal, J; Salas, JA | 1 |
| Ching, LY; Law, AY; Wong, CK; Yeung, BH | 1 |
| Chiu, PT; Hsiao, G; Hsu, MJ; Hsu, YF; Huang, YH; Kuo, WH; Lin, CH; Ou, G; Sheu, JR; Yang, DS | 1 |
| Choi, KS; Jung, EM; Kim, S; Kwon, TK; Lee, JT; Lee, TJ; Park, JW | 1 |
6 other study(ies) available for plicamycin and Colonic Neoplasms
| Article | Year |
|---|---|
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Carcinoma; Caspase 3; Caspase 8; Colonic Neoplasms; Drug Resistance, Neoplasm; HCT116 Cells; Humans; Oligopeptides; Plicamycin; Proteasome Endopeptidase Complex; RNA Interference; RNA, Small Interfering; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein | 2013 |
Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells.
Topics: Blotting, Western; Cell Death; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cytokinesis; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mitosis; Necrosis; Neoplasm Proteins; Plicamycin; Polyploidy; Transcription, Genetic; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2008 |
Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationships.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chromomycin A3; Chromomycins; Colonic Neoplasms; Deoxyribonucleases, Type II Site-Specific; DNA Restriction Enzymes; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Plicamycin; Prostatic Neoplasms; Structure-Activity Relationship | 2010 |
Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.
Topics: Cell Line, Tumor; Colonic Neoplasms; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hydroxamic Acids; Okadaic Acid; Phosphorylation; Plicamycin; Protein Synthesis Inhibitors; Repressor Proteins; Retinoblastoma Protein; Sp1 Transcription Factor; Transcription, Genetic | 2011 |
Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
Topics: AMP-Activated Protein Kinases; Apoptosis; Benzamides; Cell Proliferation; Cell Survival; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Hydroxamic Acids; Inhibitor of Apoptosis Proteins; Luciferases; Naphthols; p38 Mitogen-Activated Protein Kinases; Plicamycin; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Survivin; Transcription Factors; Tumor Suppressor Proteins | 2012 |
Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Binding Sites; Breast Neoplasms; Carcinoma, Renal Cell; Caspases; Colonic Neoplasms; Down-Regulation; Female; HT29 Cells; Humans; Male; Plicamycin; Promoter Regions, Genetic; Sp1 Transcription Factor; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2006 |